RBC Capital Comments on Biogen (BIIB) and Tecfidera PML Case; Analyst Maintains Outperform Rating
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 253.84 +12.86 (5.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.98 | 52 Week High | $333.65 | |||
| Open | $240.61 | 52 Week Low | $223.02 | |||
| Day High | $254.41 | P/E | 32.50 | |||
| Day Low | $240.02 | EPS | $7.81 | |||
| Volume | 2,237,930 | |||||
